Pfizer, Inc. Pharmaceutical preparations

Stock predictor AI models:
$ 33.83 Last close price
at 10-jul-2020

PFE

Model's trade recommendations No return for period yet

$187.48B Market Cap

β 0.68  

PFE

Model (following trade recommendations)

PFE

Underlying stock

S&P 500

Index
Return for period
0.24%
1.78%
52wk return
-20.21%
16.82%
52wk Range
28.49—43.09
2000.54—2399.63
  • 1.52 (4.50%) Div (Yield)
  • BUY Analysts consensus recommendation

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

Industry sector: Medical

Sector classification: Pharmaceutical preparations

Float 5550M
P/E 11.64
Shares Outstanding 5555M
% Held by Insiders 0.08%
% Held by Institutions 70.28%
EPS (last reported FY) $2.95
EPS (last reported Q) $0.80
EPS, estimated (last reported Q) $0.71
Total revenues $52 B
Net income $16 B